From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
J., Mikkelsen, J
We are aware of no breakthrough or accelerated regulatory designation for a neurodegenerative indication in this class, and the recent Phase 3 failures are likely to make near-term regulatory filings in this space unlikely
Other minor effects include [6]: Uneven skin pigmentation Nail pigmentation Facial flushing Headache Alteration of taste More serious side effects are rare and may include [6]: Acute priapism requiring medical intervention Heart palpitations Hematoma Abdominal pain Hyperventilation Dizziness Seizures Melanoma Clinicians caution against the use of melanotan 2 in subjects with body dysmorphic disorders, particularly as related to skin tone
Nayan Patel: Well, I wanted to share one more thing that we did last year
For a deeper look at the mechanism behind GLP-1s, read how GLP-1 actually works for weight loss